These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7842391)

  • 1. Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y.
    Laher I; Germann P; Bevan JA
    Can J Physiol Pharmacol; 1994 Sep; 72(9):1086-8. PubMed ID: 7842391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that neuropeptide Y and norepinephrine mediate electrical field-stimulated vasoconstriction of rabbit middle cerebral artery.
    Van Riper DA; Bevan JA
    Circ Res; 1991 Feb; 68(2):568-77. PubMed ID: 1671345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
    Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
    Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation.
    Burnstock G; Warland JJ
    Br J Pharmacol; 1987 Jan; 90(1):111-20. PubMed ID: 3814914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y (NPY) in the orbital arteries of the rabbit. Immunocytochemistry and vasomotor activity.
    Elsås T; Uddman R; Junping Y; Edvinsson L
    Acta Ophthalmol Scand; 1995 Dec; 73(6):517-20. PubMed ID: 9019375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery.
    von Kügelgen I; Starke K
    J Physiol; 1985 Oct; 367():435-55. PubMed ID: 2865364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for functional alpha-adrenoceptors in rabbit basilar arteries.
    Laher I; Bevan JA
    Eur J Pharmacol; 1985 Dec; 119(1-2):17-21. PubMed ID: 3002817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuropeptide Y on canine cerebral circulation.
    Suzuki Y; Shibuya M; Ikegaki I; Satoh S; Takayasu M; Asano T
    Eur J Pharmacol; 1988 Feb; 146(2-3):271-7. PubMed ID: 3371399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
    Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L
    J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature.
    Owen MP
    J Pharmacol Exp Ther; 1993 May; 265(2):887-95. PubMed ID: 8496832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man.
    Hanko JH; Törnebrandt K; Hardebo JE; Kåhrström J; Nobin A; Owman C
    J Auton Pharmacol; 1986 Jun; 6(2):117-24. PubMed ID: 3755439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y in cerebrovascular function: comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in the guinea pig basilar artery.
    Fallgren B; Arlock P; Jansen I; Edvinsson L
    Neurosci Lett; 1990 Jun; 114(1):117-22. PubMed ID: 2381572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
    Edvinsson L
    Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
    Han C; Abel PW
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in vasoconstrictor and vasodilator responses of the basilar artery during maturation in the Watanabe heritable hyperlipidemic rabbit differ from those in the New Zealand White rabbit.
    Stewart-Lee AL; Burnstock G
    Arterioscler Thromb; 1991; 11(5):1147-55. PubMed ID: 1911701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
    Vu HQ; Budai D; Duckles SP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):852-7. PubMed ID: 2600818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.